Funding for this research was provided by:
Diabetes Research Foundation Western Australia
Telethon Kids Institute
Rebecca L Cooper Medical Research Foundation
Received: 21 March 2019
Accepted: 29 August 2019
First Online: 11 November 2019
Duality of interest
: MF and RBW are members of the Scientific Advisory Board of AOBiome LLC, a company commercialising ammonia-oxidising bacteria for use in inflammatory skin disease. RBW is also a director of, and MF a scientific advisor for, RelaxSol Ltd, a company developing novel sunscreen and skincare products. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.
Free to read: This content has been made available to all.